Skip to main content

Taysha Gene Therapies, Inc 10-Q for FY2025 Q2

Taysha Gene Therapies, Inc. (TSHA)

10-Q 2025-08-12 For: 2025-06-30
View Original
Added on April 07, 2026

About this 10-Q

Taysha Gene Therapies, Inc filed this 10-Q on August 12, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.99M
up 78.6% from $1.11M a year earlier
Net loss
$26.88M
compared with a net loss of $20.93M a year earlier
Diluted EPS
-$0.09
compared with -$0.09 a year earlier